Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor.
2021
Sickle cell disease, despite its recognition as a severely debilitating genetic condition affecting hundreds of thousands of neonates throughout the world each year, was not a target of pharmaceuti...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
76
References
2
Citations
NaN
KQI